摘要
子宫内膜异位症是最常见的妇科炎症性疾病之一,该病主要发生在青年女性和处于生殖年龄期的妇女中并能导致导致不孕不育。目前,子宫内膜异位症的发病机理并不十分明确,但影响其发病过程的理论已经被提出来了,除了经典的倒经理论外,还有淋巴管和血管转移,医源性直接植入,体腔上皮化生,胚胎残余和间充质细胞分化或诱导等理论。除此之外,该病也可能涉及到胚胎性子宫内膜异位症的持续状态以及子宫内膜干/祖细胞产生的影响。本文讨论了与子宫内膜异位症的发病机制的其他危险因素如免疫、炎症、内分泌、遗传、解剖及环境因素等。目前,子宫内膜异位症的诊断依赖于与腹腔镜检查为标准的外科诊断。因此,迫切需要建立一种检测疾病早期阶段的非侵入性分子标志物,以确定子宫内膜异位症症状的检测手段。而深入了解子宫内膜异位症的病因对新型诊断方法和疾病有效治疗手段的发展至关重要。
关键词: 子宫内膜异位症发病机制,子宫内膜异位症风险因素,危险因素,妇科疾病,生物标志物的发病机制。
Current Molecular Medicine
Title:New Horizons in the Etiopathogenesis and Non-Invasive Diagnosis of Endometriosis.
Volume: 15 Issue: 8
Author(s): A Zubrzycka, M. Zubrzycki, A. Janecka and M. Zubrzycka
Affiliation:
关键词: 子宫内膜异位症发病机制,子宫内膜异位症风险因素,危险因素,妇科疾病,生物标志物的发病机制。
摘要: Endometriosis is one of the most common gynecological inflammatory diseases, occurring in adolescents and women in the reproductive age group and leading to infertility. The precise etiopathogenesis of endometriosis is unknown, but several theories concerning the phenomena involved in its development have been proposed. Beside classic retrograde menstruation, these include lymphatic and vascular metastases, iatrogenic direct implantation, coelomic metaplasia, embryonic remnants and mesenchymal cell differentiation or induction; the persistence of a form of embryonic endometriosis may also be involved, as well as the theory of the possible role of endometrial stem/progenitor cells. This paper deals with other risk factors which may be potentially involved in the etiopathogenesis of endometriosis, including the immune, inflammatory, endocrine, genetic, anatomical and environmental factors. At present, endometriosis can only be diagnosed with surgery, where laparoscopy is considered a gold standard. Therefore, there is an urgent need for a test allowing to detect non-invasive molecular biomarkers to identify the symptoms of endometriosis early on in disease development. A thorough understanding of the etiopathogenesis of endometriosis is essential toward the development of novel diagnostic assays and effective treatments of the disease.
Export Options
About this article
Cite this article as:
A Zubrzycka, M. Zubrzycki, A. Janecka and M. Zubrzycka , New Horizons in the Etiopathogenesis and Non-Invasive Diagnosis of Endometriosis., Current Molecular Medicine 2015; 15 (8) . https://dx.doi.org/10.2174/1566524015666150921105218
DOI https://dx.doi.org/10.2174/1566524015666150921105218 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Continuous Nanostructures for the Controlled Release of Drugs
Current Pharmaceutical Design New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Current Medicinal Chemistry Validation and Development of N-glycan as Biomarker in Cancer Diagnosis
Current Pharmacogenomics and Personalized Medicine Synthesis and Evaluation of Cytotoxic Activity of Certain Benzo[h]chromene Derivatives
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Structure Activity Relationship Study of N-substituted 3,5-diarylidenepiperidin- 4-ones as Potential Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry Management of Fallopian Tube Cancer
Reviews on Recent Clinical Trials Mitochondrial Physiology and Toxicity (Mitotoxicity); Importance for the Immune System, Programmed Cell Death and Cancer
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Nanocarriers to Solid Tumors: Considerations on Tumor Penetration and Exposure of Tumor Cells to Therapeutic Agents
Current Pharmaceutical Biotechnology Inhibition of Apoptosis in Pediatric Cancer by Survivin
Current Pediatric Reviews Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets Clinical Approaches Toward Tumor Angiogenesis: Past, Present and Future
Current Pharmaceutical Design Emerging Role of Circular RNAs in Kidney Diseases in Nephrology
Current Drug Targets Epithelial-Mesenchymal Transition: Implications in Cancer Progression and Metastasis
Current Pharmaceutical Biotechnology LHON: Mitochondrial Mutations and More
Current Genomics Patents on Immunotoxins and Chimeric Toxins for the Treatment of Cancer
Recent Patents on Drug Delivery & Formulation Silencing of Disease-related Genes by Small Interfering RNAs
Current Molecular Medicine Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics
Current Pharmaceutical Biotechnology Platinum Formulations as Anticancer Drugs Clinical and Pre-Clinical Studies
Current Topics in Medicinal Chemistry PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies
Reviews on Recent Clinical Trials Mesenchymal Stem Cells and Their Cell Surface Receptors
Current Rheumatology Reviews